Eric Van Cutsem, MD, PhD, discusses regorafenib for the treatment of patients with chemorefractory metastatic colorectal cancer (mCRC).
Eric Van Cutsem, MD, PhD
Articles by Eric Van Cutsem, MD, PhD
Eric Van Cutsem, MD, PhD, discusses the challenges of using chemotherapy to treat patients with gastric cancer.
Latest Updated Articles
Dr. Van Cutsem Discusses Regorafenib for the Treatment of Patients With Chemorefractory mCRCPublished: August 21st 2015 | Updated:
Chemotherapy Treatment in Gastric CancerPublished: February 6th 2015 | Updated: